Our Senior Accountant, Kayla H., reflects on “Why Alcresta?” and how her accounting experience connects to a purpose that goes well beyond her career. Thanks for sharing, Kayla! #WhyAlcresta #EmployeeSpotlight
Alcresta Therapeutics
医疗设备制造业
Newton，MA 2,600 位关注者
Fulfilling potential: With the Science of Enzymes
关于我们
Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. The company uses its proprietary technology platform to support a broad pipeline of products, with an initial focus on pancreatic insufficiency or fat malabsorption, which results in malabsorption common in cystic fibrosis, digestive cancers, preterm birth, and other serious diseases. The company’s lead product, RELiZORB®, is designed to reliably and efficiently deliver the optimal nutritional and caloric benefit from existing enteral feeding formulas by improving the breakdown and absorption of fats, in particular long-chain polyunsaturated fatty acids like omega-3 (including DHA, EPA). RELiZORB is indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula. The company’s platform is supported by our extensive experience in pharmaceutical, medical device and nutritional product development. Based in Massachusetts, the company is backed by top-tier venture investors Athyrium Capital Management, Bessemer Venture Partners, Frazier Healthcare, and Third Rock Ventures.
- 网站
-
http://www.alcresta.com
Alcresta Therapeutics的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Newton，MA
- 类型
- 私人持股
- 创立
- 2011
地点
-
主要
获取路线
One Newton Executive Park
Suite 100
US，MA，Newton，02462
Alcresta Therapeutics员工
动态
-
Interested in joining a team united by the shared goal of improving nutritional care in people with rare diseases? Explore our open positions: https://lnkd.in/gfcZ7UUj #WereHiring #Hiring #JoinOurTeam
-
-
Individuals with #rarediseases often rely on #tubefeeding to meet their nutritional needs. To better support these patients, we are developing a portfolio of enzyme-based, point-of-care products designed for #enteral nutrition. Learn about our science: https://lnkd.in/g9YJ-9_r #FTAW #tubefeeding
-
-
According to The Oley Foundation, it’s estimated that 438,000 people in the US are managing #tubefeeding at home. Our enzyme-based products are designed to support the nutritional needs of tube-fed patients. Learn more: https://www.alcresta.com/ #FeedingTubeAwarenessWeek #FTAW
-
-
It’s #FeedingTubeAwarenessWeek! We are proud to join fellow advocates in promoting awareness of #enteral nutrition and working toward better outcomes for #tubefed patients. Learn more about our ongoing efforts to address the challenges of #tubefeeding: https://www.alcresta.com/ #FTAW
-
-
Alcresta is excited to share the announcement of FDA Expanded Use Clearance for RELiZORB® (iMMOBILIZED LIPASE) Cartridge for Pediatric Patients Down to Age 1 Year Old. Read the full release: https://lnkd.in/euGmtSJX
-
Effective #fatabsorption can boost nutrient uptake, enhance energy levels, support growth and reduce complications from deficiencies. We're committed to developing innovations that improve fat absorption and nutritional health for individuals with #rarediseases. Learn more: https://www.alcresta.com/
-
-
[The Oley Foundation is sharing this information on behalf of our corporate partner, #Alcresta Therapeutics.] Every journey with a feeding tube is unique. RELiZORB supports fat absorption and elevates your tube feeds, so you or your loved one can focus on living fully. Learn more about how RELiZORB makes a difference on our website: www.relizorb.com. RELiZORB® (iMMOBILIZED LIPASE) CARTRIDGE is indicated for use in pediatric patients (ages 2 years and above) and adult patients to hydrolyze fats in enteral formula. RELiZORB is for use with enteral feeding only. RELiZORB should not be connected to an intravenous (IV) line, setup, or system. Medications should not be administered through RELiZORB. See RELiZORB’s full Important Safety Information at https://lnkd.in/eA5b7YKU
-
-
Our Senior Laboratory Operations Manager, Megan C., reflects on how her journey at Alcresta has supported her growth both professionally and personally. Thanks for sharing, Megan. We’re grateful to have you on our team! #WhyAlcresta #EmployeeSpotlight
-